Literature DB >> 11432858

Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine.

L S Mizoue1, S K Sullivan, D S King, T N Kledal, T W Schwartz, K B Bacon, T M Handel.   

Abstract

Fractalkine/CX3CL1 is a membrane-tethered chemokine that functions as a chemoattractant and adhesion protein by interacting with the receptor CX3CR1. To understand the molecular basis for the interaction, an extensive mutagenesis study of fractalkine's chemokine domain was undertaken. The results reveal a cluster of basic residues (Lys-8, Lys-15, Lys-37, Arg-45, and Arg-48) and one aromatic (Phe-50) that are critical for binding and/or signaling. The mutant R48A could bind but not induce chemotaxis, demonstrating that Arg-48 is a signaling trigger. This result also shows that signaling residues are not confined to chemokine N termini, as generally thought. F50A showed no detectable binding, underscoring its importance to the stability of the complex. K15A displayed unique signaling characteristics, eliciting a wild-type calcium flux but minimal chemotaxis, suggesting that this mutant can activate some, but not all, pathways required for migration. Fractalkine also binds the human cytomegalovirus receptor US28, and analysis of the mutants indicates that US28 recognizes many of the same epitopes of fractalkine as CX3CR1. Comparison of the binding surfaces of fractalkine and the CC chemokine MCP-1 reveals structural details that may account for their dual recognition by US28 and their selective recognition by host receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432858     DOI: 10.1074/jbc.M101348200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The Tim9p-Tim10p complex binds to the transmembrane domains of the ADP/ATP carrier.

Authors:  Sean P Curran; Danielle Leuenberger; Wolfgang Oppliger; Carla M Koehler
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

Review 2.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

Review 3.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 4.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

5.  On-column refolding of recombinant chemokines for NMR studies and biological assays.

Authors:  Christopher T Veldkamp; Francis C Peterson; Paulette L Hayes; Jessie E Mattmiller; John C Haugner; Norberto de la Cruz; Brian F Volkman
Journal:  Protein Expr Purif       Date:  2006-09-24       Impact factor: 1.650

6.  Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.

Authors:  Oliver Hartley; Karim Dorgham; Danielle Perez-Bercoff; Fabrice Cerini; Anouk Heimann; Hubert Gaertner; Robin E Offord; Gianfranco Pancino; Patrice Debré; Guy Gorochov
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.

Authors:  Masaaki Fujita; Yoko K Takada; Yoshikazu Takada
Journal:  J Immunol       Date:  2012-11-02       Impact factor: 5.422

8.  Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.

Authors:  Joshua J Ziarek; Yan Liu; Emmanuel Smith; Guolin Zhang; Francis C Peterson; Jun Chen; Yongping Yu; Yu Chen; Brian F Volkman; Rongshi Li
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

9.  Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases.

Authors:  Yi-Wei Huang; Paul Su; Guang Ying Liu; Min Rui Crow; Deanna Chaukos; Harry Yan; Lisa A Robinson
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

10.  BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies.

Authors:  Abhiram Dukkipati; Hyun Ho Park; Deepa Waghray; Suzanne Fischer; K Christopher Garcia
Journal:  Protein Expr Purif       Date:  2008-08-22       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.